Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. de Souza, CJ; Russo, P; Lozito, R; Dunning, BE
   Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions
   DIABETES OBESITY & METABOLISM
   
   C.J. de Souza et al., "Differential effects of short and long duration insulinotropic agents on meal-related glucose excursions", DIABET OB M, 3(2), 2001, pp. 73-83
2. Kerchner, GA; Wei, F; Wang, GD; Kim, SJ; Xu, HM; Robinson, DA; Li, P; Chen, ZF; Zhuo, M
   Do 'smart' mice feel more pain, or are they just better learners? Reply
   NATURE NEUROSCIENCE
   
   G.A. Kerchner et al., "Do 'smart' mice feel more pain, or are they just better learners? Reply", NAT NEUROSC, 4(5), 2001, pp. 453-454
3. Bolli, GB
   Physiological insulin replacement in type 1 diabetes mellitus
   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
   
   G.B. Bolli, "Physiological insulin replacement in type 1 diabetes mellitus", EXP CL E D, 109, 2001, pp. S317-S332
4. D'Alessandro, AG; Martemucci, G; Colonna, MA; Borghese, A; Terzano, MG; Bellitti, A
   Superovulation in ewes by a single injection of pFSH dissolved in polyvinylpyrrolidone (PVP): effects of PVP molecular weight, concentration and schedule of treatment
   ANIMAL REPRODUCTION SCIENCE
   
   A.G. D'Alessandro et al., "Superovulation in ewes by a single injection of pFSH dissolved in polyvinylpyrrolidone (PVP): effects of PVP molecular weight, concentration and schedule of treatment", ANIM REPROD, 65(3-4), 2001, pp. 255-264
5. Knudsen, LB; Agerso, H; Bjenning, C; Bregenholt, S; Carr, RD; Godtfredsen, C; Holst, JJ; Huusfeldt, PO; Larsen, MO; Larsen, PJ; Nielsen, PF; Ribel, U; Rolin, B; Romer, J; Sturis, J; Wilken, M; Kristensen, P
   GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development
   DRUGS OF THE FUTURE
   
   L.B. Knudsen et al., "GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes:selection of NN2211 for clinical development", DRUG FUTURE, 26(7), 2001, pp. 677-685
6. Chan, H
   Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin
   JOURNAL OF ADVANCED NURSING
   
   H. Chan, "Effects of injection duration on site-pain intensity and bruising associated with subcutaneous heparin", J ADV NURS, 35(6), 2001, pp. 882-892
7. Chen, HS; Chen, J; Chen, J; Guo, WG; Zheng, MH
   Establishment of bee venom-induced contralateral heat hyperalgesia in the rat is dependent upon central temporal summation of afferent input from thesite of injury
   NEUROSCIENCE LETTERS
   
   H.S. Chen et al., "Establishment of bee venom-induced contralateral heat hyperalgesia in the rat is dependent upon central temporal summation of afferent input from thesite of injury", NEUROSCI L, 298(1), 2001, pp. 57-60
8. Linglof, T; van Hattum, J; Kaplan, KM; Corrigan, J; Duval, I; Jensen, E; Kuter, B
   An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity
   VACCINE
   
   T. Linglof et al., "An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA((R))) in adults: safety, tolerability, and immunogenicity", VACCINE, 19(28-29), 2001, pp. 3968-3971
9. Porter, CJH; Edwards, GA; Charman, SA
   Lymphatic transport of proteins after s.c. injection: implications of animal model selection
   ADVANCED DRUG DELIVERY REVIEWS
   
   C.J.H. Porter et al., "Lymphatic transport of proteins after s.c. injection: implications of animal model selection", ADV DRUG DE, 50(1-2), 2001, pp. 157-171
10. Nishioka, Y; Yoshino, H
    Lymphatic targeting with nanoparticulate system
    ADVANCED DRUG DELIVERY REVIEWS
    
    Y. Nishioka e H. Yoshino, "Lymphatic targeting with nanoparticulate system", ADV DRUG DE, 47(1), 2001, pp. 55-64
11. Goins, BA; Phillips, WT
    The use of scintigraphic imaging as a tool in the development of liposome formulations
    PROGRESS IN LIPID RESEARCH
    
    B.A. Goins e W.T. Phillips, "The use of scintigraphic imaging as a tool in the development of liposome formulations", PROG LIPID, 40(1-2), 2001, pp. 95-123
12. Vajo, Z; Fawcett, J; Duckworth, WC
    Recombinant DNA technology in the treatment of diabetes: Insulin analogs
    ENDOCRINE REVIEWS
    
    Z. Vajo et al., "Recombinant DNA technology in the treatment of diabetes: Insulin analogs", ENDOCR REV, 22(5), 2001, pp. 706-717
13. Breit, S; Rueff, F; Przybilla, B
    'Deep impact' contact allergy after subcutaneous injection of local anesthetics
    CONTACT DERMATITIS
    
    S. Breit et al., "'Deep impact' contact allergy after subcutaneous injection of local anesthetics", CONTACT DER, 45(5), 2001, pp. 296-297
14. Lian, T; Ho, RJY
    Trends and developments in liposome drug delivery systems
    JOURNAL OF PHARMACEUTICAL SCIENCES
    
    T. Lian e R.J.Y. Ho, "Trends and developments in liposome drug delivery systems", J PHARM SCI, 90(6), 2001, pp. 667-680
15. Lehnert, H; Klose, S; Kerner, W
    Short-acting and long-acting insulin analogs - Advantages and disadvantages relative to regular insulin
    INTERNIST
    
    H. Lehnert et al., "Short-acting and long-acting insulin analogs - Advantages and disadvantages relative to regular insulin", INTERNIST, 42, 2001, pp. S29
16. Kuzu, N; Ucar, H
    The effect of cold on the occurrence of bruising, haematoma and pain at the injection site in subcutaneous low molecular weight heparin
    INTERNATIONAL JOURNAL OF NURSING STUDIES
    
    N. Kuzu e H. Ucar, "The effect of cold on the occurrence of bruising, haematoma and pain at the injection site in subcutaneous low molecular weight heparin", INT J NURS, 38(1), 2001, pp. 51-59
17. Larche, M
    Inhibition of human T-cell responses by allergen peptides
    IMMUNOLOGY
    
    M. Larche, "Inhibition of human T-cell responses by allergen peptides", IMMUNOLOGY, 104(4), 2001, pp. 377-382
18. McKeage, K; Goa, KL
    Insulin glargine - A review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus
    DRUGS
    
    K. McKeage e K.L. Goa, "Insulin glargine - A review of its therapeutic use as a long-acting agent for the management of type 1 and 2 diabetes mellitus", DRUGS, 61(11), 2001, pp. 1599-1624
19. de la Motte, S; Klinger, J; Kefer, G; King, T; Harrison, F
    Pharmacokinetics of human growth hormone administered subcutaneously with two different injection systems
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH
    
    S. de la Motte et al., "Pharmacokinetics of human growth hormone administered subcutaneously with two different injection systems", ARZNEI-FOR, 51(7), 2001, pp. 613-617
20. Heinemann, L; Heise, T
    Clinical efficacy and pharmacodynamics of the insulin analogs lispro, aspart and glargin
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
    
    L. Heinemann e T. Heise, "Clinical efficacy and pharmacodynamics of the insulin analogs lispro, aspart and glargin", DEUT MED WO, 126(20), 2001, pp. 597-604
21. Neville, ME; Boni, LT; Pflug, LE; Popescu, MC; Robb, RJ
    Biopharmaceutics of liposomal interleukin 2, Oncolipin
    CYTOKINE
    
    M.E. Neville et al., "Biopharmaceutics of liposomal interleukin 2, Oncolipin", CYTOKINE, 12(11), 2000, pp. 1691-1701
22. Heinzerling, L; Dummer, R; Wildberger, H; Burg, G
    Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient
    DERMATOLOGY
    
    L. Heinzerling et al., "Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient", DERMATOLOGY, 201(2), 2000, pp. 154-157
23. Vereecken, M; De Herdt, P; Ducatelle, R; Haesebrouck, F
    The effect of vaccination on the course of an experimental Salmonella typhimurium infection in racing pigeons
    AVIAN PATHOLOGY
    
    M. Vereecken et al., "The effect of vaccination on the course of an experimental Salmonella typhimurium infection in racing pigeons", AVIAN PATH, 29(5), 2000, pp. 465-471
24. Li, KC; Zheng, JH; Chen, J
    Involvement of spinal protein kinase C in induction and maintenance of both persistent spontaneous flinching reflex and contralateral heat hyperalgesia induced by subcutaneous bee venom in the conscious rat
    NEUROSCIENCE LETTERS
    
    K.C. Li et al., "Involvement of spinal protein kinase C in induction and maintenance of both persistent spontaneous flinching reflex and contralateral heat hyperalgesia induced by subcutaneous bee venom in the conscious rat", NEUROSCI L, 285(2), 2000, pp. 103-106
25. Chen, HS; Chen, J; Sun, YY
    Contralateral heat hyperalgesia induced by unilaterally intraplantar bee venom injection is produced by central changes: a behavioral study in the conscious rat
    NEUROSCIENCE LETTERS
    
    H.S. Chen et al., "Contralateral heat hyperalgesia induced by unilaterally intraplantar bee venom injection is produced by central changes: a behavioral study in the conscious rat", NEUROSCI L, 284(1-2), 2000, pp. 45-48
26. Arroyo, CM; Schafer, RJ; Carmichael, AJ
    Reactivity of chloroethyl sulfides in the presence of a chlorinated prophylactic: A kinetic study by EPR/spin trapping and NMR techniques
    JOURNAL OF APPLIED TOXICOLOGY
    
    C.M. Arroyo et al., "Reactivity of chloroethyl sulfides in the presence of a chlorinated prophylactic: A kinetic study by EPR/spin trapping and NMR techniques", J APPL TOX, 21, 2000, pp. S7-S12
27. Arroyo, CM; Schafer, RJ; Carmichael, AJ
    Reactivity of chloroethyl sulfides in the presence of a chlorinated prophylactic: a kinetic study by EPR/spin trapping and NMR techniques
    JOURNAL OF APPLIED TOXICOLOGY
    
    C.M. Arroyo et al., "Reactivity of chloroethyl sulfides in the presence of a chlorinated prophylactic: a kinetic study by EPR/spin trapping and NMR techniques", J APPL TOX, 20, 2000, pp. S7-S12
28. Sparsa, A; Loustaud-Ratti, V; Liozon, E; Denes, E; Soria, P; Bouyssou-Gauthier, ML; Le Brun, V; Boulinguez, S; Bedane, C; Scribbe-Outtas, M; Outtas, O; Labrousse, F; Bonnetblanc, JM; Bordessoule, D; Vidal, E
    Cutaneous reaction or necrosis in response to interferon alpha: can interferon be reintroduced after healing? Six case reports.
    REVUE DE MEDECINE INTERNE
    
    A. Sparsa et al., "Cutaneous reaction or necrosis in response to interferon alpha: can interferon be reintroduced after healing? Six case reports.", REV MED IN, 21(9), 2000, pp. 756-763
29. Boyd, AS; Seger, D; Vannucci, S; Langley, M; Abraham, JL; King, LE
    Mercury exposure and cutaneous disease
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
    
    A.S. Boyd et al., "Mercury exposure and cutaneous disease", J AM ACAD D, 43(1), 2000, pp. 81-90
30. Goossens, L
    Efficacy and safety of subcutaneous injection of Nuflor (R) in cattle
    TIERARZTLICHE UMSCHAU
    
    L. Goossens, "Efficacy and safety of subcutaneous injection of Nuflor (R) in cattle", TIER UMSCH, 55(10), 2000, pp. 563-565
31. Phillips, WT; Klipper, R; Goins, B
    Novel method of greatly enhanced delivery of liposomes to lymph nodes
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    
    W.T. Phillips et al., "Novel method of greatly enhanced delivery of liposomes to lymph nodes", J PHARM EXP, 295(1), 2000, pp. 309-313
32. Knox, RV; Tudor, KW; Rodriguez-Zas, SL; Robb, JA
    Effect of subcutaneous vs intramuscular administration of PG 600 on estrual and ovulatory responses of prepubertal gilts
    JOURNAL OF ANIMAL SCIENCE
    
    R.V. Knox et al., "Effect of subcutaneous vs intramuscular administration of PG 600 on estrual and ovulatory responses of prepubertal gilts", J ANIM SCI, 78(7), 2000, pp. 1732-1737
33. von Garnier, C; Astori, M; Kettner, A; Dufour, N; Heusser, C; Corradin, G; Spertini, F
    Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis
    EUROPEAN JOURNAL OF IMMUNOLOGY
    
    C. von Garnier et al., "Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis", EUR J IMMUN, 30(6), 2000, pp. 1638-1645
34. Bestman-Smith, J; Gourde, P; Desormeaux, A; Tremblay, MJ; Bergeron, MG
    Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    
    J. Bestman-Smith et al., "Sterically stabilized liposomes bearing anti-HLA-DR antibodies for targeting the primary cellular reservoirs of HIV-1", BBA-BIOMEMB, 1468(1-2), 2000, pp. 161-174
35. Kuno, T; Tashiro, K; Sato, T; Tasaki, H; Miyazaki, S
    Continuous subcutaneous insulin injection for a case of mitochondrial cytopathy with diabetes mellitus requiring a large amount of insulin
    PEDIATRICS INTERNATIONAL
    
    T. Kuno et al., "Continuous subcutaneous insulin injection for a case of mitochondrial cytopathy with diabetes mellitus requiring a large amount of insulin", PEDIATR INT, 41(1), 1999, pp. 97-100
36. Fielding, RM; Moon-McDermott, L; Lewis, RO
    Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration
    JOURNAL OF DRUG TARGETING
    
    R.M. Fielding et al., "Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration", J DRUG TAR, 6(6), 1999, pp. 415-426
37. Sone, T; Morikubo, K; Shimizu, K; Komiyama, N; Tsunoo, H; Kino, K
    Peptide specificity, HLA class II restriction, and T-cell subsets of the T-cell clones specific to either Cry j 1 or Cry j 2, the major allergens of Japanese cedar (Cryptomeria japonica) pollen
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    
    T. Sone et al., "Peptide specificity, HLA class II restriction, and T-cell subsets of the T-cell clones specific to either Cry j 1 or Cry j 2, the major allergens of Japanese cedar (Cryptomeria japonica) pollen", INT A AL IM, 119(3), 1999, pp. 185-196
38. Janezic, T
    Injector: a simple device to inject large quantities of vasopressor-anesthetic solutions
    EUROPEAN JOURNAL OF PLASTIC SURGERY
    
    T. Janezic, "Injector: a simple device to inject large quantities of vasopressor-anesthetic solutions", EUR J PLAST, 22(4), 1999, pp. 195-196
39. Naschitz, JE; Bejar, J; Mogilner, J; Misselevich, I; Steiner, Z; Eldar, S; Yeshurun, D; Boss, JH
    Acute lipase-induced panniculitis in rats with ligated veins of the hindlimb: a contribution to the role of acute panniculitis as a precursor of lipodermatosclerosis of venous disease
    JOURNAL OF DERMATOLOGICAL SCIENCE
    
    J.E. Naschitz et al., "Acute lipase-induced panniculitis in rats with ligated veins of the hindlimb: a contribution to the role of acute panniculitis as a precursor of lipodermatosclerosis of venous disease", J DERMA SCI, 19(1), 1999, pp. 9-16
40. Kitchen, S; Iampietro, R; Woolley, AM; Preston, FE
    Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability
    THROMBOSIS AND HAEMOSTASIS
    
    S. Kitchen et al., "Anti Xa monitoring during treatment with low molecular weight heparin or danaparoid: Inter-assay variability", THROMB HAEM, 82(4), 1999, pp. 1289-1293
41. Pieber, TR
    Long acting insulin analogues: Can they provide a basal insulin level?
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM
    
    T.R. Pieber, "Long acting insulin analogues: Can they provide a basal insulin level?", J PED END M, 12, 1999, pp. 745-750
42. Wagner, JP; Black, IB; DiCicco-Bloom, E
    Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor
    JOURNAL OF NEUROSCIENCE
    
    J.P. Wagner et al., "Stimulation of neonatal and adult brain neurogenesis by subcutaneous injection of basic fibroblast growth factor", J NEUROSC, 19(14), 1999, pp. 6006-6016
43. Mark, A; Carlsson, RM; Granstrom, M
    Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents
    VACCINE
    
    A. Mark et al., "Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents", VACCINE, 17(15-16), 1999, pp. 2067-2072
44. Phillips, WT
    Delivery of gamma-imaging agents by liposomes
    ADVANCED DRUG DELIVERY REVIEWS
    
    W.T. Phillips, "Delivery of gamma-imaging agents by liposomes", ADV DRUG DE, 37(1-3), 1999, pp. 13-32
45. Emilien, G; Maloteaux, JM; Ponchon, M
    Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment
    PHARMACOLOGY & THERAPEUTICS
    
    G. Emilien et al., "Pharmacological management of diabetes: Recent progress and future perspective in daily drug treatment", PHARM THERA, 81(1), 1999, pp. 37-51
46. Hamel, FG; Siford, GL; Fawcett, J; Chance, RE; Frank, BH; Duckworth, WC
    Differences in the cellular processing of Asp(B10) human insulin compared with human insulin and Lys(B28)Pro(B29) human insulin
    METABOLISM-CLINICAL AND EXPERIMENTAL
    
    F.G. Hamel et al., "Differences in the cellular processing of Asp(B10) human insulin compared with human insulin and Lys(B28)Pro(B29) human insulin", METABOLISM, 48(5), 1999, pp. 611-617
47. Lin, SS; Wang, SY; Chen, EC; Chien, YW
    Insulin lispro: In-vivo potency determination by intravenous administration in conscious rabbits
    JOURNAL OF PHARMACY AND PHARMACOLOGY
    
    S.S. Lin et al., "Insulin lispro: In-vivo potency determination by intravenous administration in conscious rabbits", J PHARM PHA, 51(3), 1999, pp. 301-306
48. Schramm, G; Kahlert, H; Suck, R; Weber, B; Stuwe, HT; Muller, WD; Bufe, A; Becker, WM; Schlaak, MW; Jager, L; Cromwell, O; Fiebig, H
    "Allergen engineering": Variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity
    JOURNAL OF IMMUNOLOGY
    
    G. Schramm et al., ""Allergen engineering": Variants of the timothy grass pollen allergen Phl p 5b with reduced IgE-binding capacity but conserved T cell reactivity", J IMMUNOL, 162(4), 1999, pp. 2406-2414
49. Balkan, B; Kwasnik, L; Miserendino, R; Holst, JJ; Li, X
    Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obeseZucker rats
    DIABETOLOGIA
    
    B. Balkan et al., "Inhibition of dipeptidyl peptidase IV with NVP-DPP728 increases plasma GLP-1 (7-36 amide) concentrations and improves oral glucose tolerance in obeseZucker rats", DIABETOLOG, 42(11), 1999, pp. 1324-1331
50. Chen, J; Li, HL; Luo, C; Li, Z; Zheng, JH
    Involvement of peripheral NMDA and non-NMDA receptors in development of persistent firing of spinal wide-dynamic-range neurons induced by subcutaneous bee venom injection in the cat
    BRAIN RESEARCH
    
    J. Chen et al., "Involvement of peripheral NMDA and non-NMDA receptors in development of persistent firing of spinal wide-dynamic-range neurons induced by subcutaneous bee venom injection in the cat", BRAIN RES, 844(1-2), 1999, pp. 98-105
51. Dufresne, I; Desormeaux, A; Bestman-Smith, J; Gourde, P; Tremblay, MJ; Bergeron, MG
    Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
    
    I. Dufresne et al., "Targeting lymph nodes with liposomes bearing anti-HLA-DR Fab' fragments", BBA-BIOMEMB, 1421(2), 1999, pp. 284-294
52. Nobels, FR; Hermans, MP; De Leeuw, I
    Insulin lispro (Humalog((R))), a novel fast-acting insulin analogue: Guidelines for its practical use
    ACTA CLINICA BELGICA
    
    F.R. Nobels et al., "Insulin lispro (Humalog((R))), a novel fast-acting insulin analogue: Guidelines for its practical use", ACT CLIN B, 54(5), 1999, pp. 246-254
53. BENBARKA MM; PRESCOTT PT; AOKI TT
    PRACTICAL GUIDELINES ON THE USE OF INSULIN LISPRO IN ELDERLY DIABETIC-PATIENTS
    Drugs & aging
    
    M.M. Benbarka et al., "PRACTICAL GUIDELINES ON THE USE OF INSULIN LISPRO IN ELDERLY DIABETIC-PATIENTS", Drugs & aging, 12(2), 1998, pp. 103-113
54. LEE WL; ZINMAN B
    FROM INSULIN TO INSULIN ANALOGS - PROGRESS IN THE TREATMENT OF TYPE-1DIABETES
    Diabetes reviews
    
    W.L. Lee e B. Zinman, "FROM INSULIN TO INSULIN ANALOGS - PROGRESS IN THE TREATMENT OF TYPE-1DIABETES", Diabetes reviews, 6(2), 1998, pp. 73-88
55. Amir, A; Chapman, S; Gozes, Y; Sahar, R; Allon, N
    Protection by extracellular glutathione against sulfur mustard induced toxicity in vitro
    HUMAN & EXPERIMENTAL TOXICOLOGY
    
    A. Amir et al., "Protection by extracellular glutathione against sulfur mustard induced toxicity in vitro", HUM EXP TOX, 17(12), 1998, pp. 652-660
56. VANHOEYVELD EM; ESCALONAMONGE M; DESWERT LFA; STEVENS EAM
    ALLERGENIC AND ANTIGENIC ACTIVITY OF PEPTIDE-FRAGMENTS IN A WHEY HYDROLYSATE FORMULA
    Clinical and experimental allergy
    
    E.M. Vanhoeyveld et al., "ALLERGENIC AND ANTIGENIC ACTIVITY OF PEPTIDE-FRAGMENTS IN A WHEY HYDROLYSATE FORMULA", Clinical and experimental allergy, 28(9), 1998, pp. 1131-1137
57. LATIMER PR; HODGKINS PR; VAKALIS AN; BUTLER RE; EVANS AR; ZAKI GA
    NECROTIZING FASCIITIS AS A COMPLICATION OF BOTULINUM TOXIN INJECTION
    Eye
    
    P.R. Latimer et al., "NECROTIZING FASCIITIS AS A COMPLICATION OF BOTULINUM TOXIN INJECTION", Eye, 12, 1998, pp. 51-53
58. SVARTBERG J; HOLST JJ; GUTNIAK M; ADNER N
    THE ETHANOL AUGMENTATION OF GLUCOSE-INDUCED INSULIN-SECRETION IS ABOLISHED BY CALCIUM ANTAGONISM WITH NIFEDIPINE - NO EVIDENCE FOR A ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)
    Pancreas
    
    J. Svartberg et al., "THE ETHANOL AUGMENTATION OF GLUCOSE-INDUCED INSULIN-SECRETION IS ABOLISHED BY CALCIUM ANTAGONISM WITH NIFEDIPINE - NO EVIDENCE FOR A ROLE OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1)", Pancreas, 16(1), 1998, pp. 66-71
59. PUTTAGUNTA AL; TOTH EL
    INSULIN LISPRO (HUMALOG), THE FIRST MARKETED INSULIN ANALOG - INDICATIONS, CONTRAINDICATIONS AND NEED FOR FURTHER STUDY
    CMAJ. Canadian Medical Association journal
    
    A.L. Puttagunta e E.L. Toth, "INSULIN LISPRO (HUMALOG), THE FIRST MARKETED INSULIN ANALOG - INDICATIONS, CONTRAINDICATIONS AND NEED FOR FURTHER STUDY", CMAJ. Canadian Medical Association journal, 158(4), 1998, pp. 506-511
60. DELSINDACO P; CIOFETTA M; LALLI C; PERRIELLO G; PAMPANELLI S; TORLONE E; BRUNETTI P; BOLLI GB
    USE OF THE SHORT-ACTING INSULIN ANALOG LISPRO IN INTENSIVE TREATMENT OF TYPE-1 DIABETES-MELLITUS - IMPORTANCE OF APPROPRIATE REPLACEMENT OFBASAL INSULIN AND TIME-INTERVAL INJECTION-MEAL
    Diabetic medicine
    
    P. Delsindaco et al., "USE OF THE SHORT-ACTING INSULIN ANALOG LISPRO IN INTENSIVE TREATMENT OF TYPE-1 DIABETES-MELLITUS - IMPORTANCE OF APPROPRIATE REPLACEMENT OFBASAL INSULIN AND TIME-INTERVAL INJECTION-MEAL", Diabetic medicine, 15(7), 1998, pp. 592-600
61. ALIBAZOGLU H; MEGREMIS D; ALI A; LAMONICA G
    INJECTION ARTIFACT ON FDG PET IMAGING
    Clinical nuclear medicine
    
    H. Alibazoglu et al., "INJECTION ARTIFACT ON FDG PET IMAGING", Clinical nuclear medicine, 23(4), 1998, pp. 264-265
62. AHMED ABE; MALLIAS J; HOME PD
    OPTIMIZATION OF EVENING INSULIN DOSE IN PATIENTS USING THE SHORT-ACTING INSULIN ANALOG LISPRO
    Diabetes care
    
    A.B.E. Ahmed et al., "OPTIMIZATION OF EVENING INSULIN DOSE IN PATIENTS USING THE SHORT-ACTING INSULIN ANALOG LISPRO", Diabetes care, 21(7), 1998, pp. 1162-1166
63. NAUCK MA; SAUERWALD A; RITZEL R; HOLST JJ; SCHMIEGEL W
    INFLUENCE OF GLUCAGON-LIKE PEPTIDE 1 ON FASTING GLYCEMIA IN TYPE-2 DIABETIC-PATIENTS TREATED WITH INSULIN AFTER SULFONYLUREA SECONDARY FAILURE
    Diabetes care
    
    M.A. Nauck et al., "INFLUENCE OF GLUCAGON-LIKE PEPTIDE 1 ON FASTING GLYCEMIA IN TYPE-2 DIABETIC-PATIENTS TREATED WITH INSULIN AFTER SULFONYLUREA SECONDARY FAILURE", Diabetes care, 21(11), 1998, pp. 1925-1931
64. BRUNELLE RL; LLEWELYN J; ANDERSON JH; GALE EAM; KOIVISTO VA
    METAANALYSIS OF THE EFFECT OF INSULIN LISPRO ON SEVERE HYPOGLYCEMIA IN PATIENTS WITH TYPE-1 DIABETES
    Diabetes care
    
    R.L. Brunelle et al., "METAANALYSIS OF THE EFFECT OF INSULIN LISPRO ON SEVERE HYPOGLYCEMIA IN PATIENTS WITH TYPE-1 DIABETES", Diabetes care, 21(10), 1998, pp. 1726-1731
65. AHMED ABE; HOME PD
    THE EFFECT OF THE INSULIN ANALOG LISPRO ON NIGHTTIME BLOOD-GLUCOSE CONTROL IN TYPE-1 DIABETIC-PATIENTS
    Diabetes care
    
    A.B.E. Ahmed e P.D. Home, "THE EFFECT OF THE INSULIN ANALOG LISPRO ON NIGHTTIME BLOOD-GLUCOSE CONTROL IN TYPE-1 DIABETIC-PATIENTS", Diabetes care, 21(1), 1998, pp. 32-37
66. SIMONS FER; ROBERTS JR; GU XC; SIMONS KJ
    EPINEPHRINE ABSORPTION IN CHILDREN WITH A HISTORY OF ANAPHYLAXIS
    Journal of allergy and clinical immunology
    
    F.E.R. Simons et al., "EPINEPHRINE ABSORPTION IN CHILDREN WITH A HISTORY OF ANAPHYLAXIS", Journal of allergy and clinical immunology, 101(1), 1998, pp. 33-37
67. REIS EC; JACOBSON RM; TARBELL S; WENIGER BG
    TAKING THE STING OUT OF SHOTS - CONTROL OF VACCINATION-ASSOCIATED PAIN AND ADVERSE REACTIONS
    Pediatric annals
    
    E.C. Reis et al., "TAKING THE STING OUT OF SHOTS - CONTROL OF VACCINATION-ASSOCIATED PAIN AND ADVERSE REACTIONS", Pediatric annals, 27(6), 1998, pp. 375-386
68. DYSARZ FA; FIORILLO MA; DAVIDSON PG
    COMPLICATIONS OF SUBCUTANEOUS INJECTION PORTS
    The Mount Sinai journal of medicine
    
    F.A. Dysarz et al., "COMPLICATIONS OF SUBCUTANEOUS INJECTION PORTS", The Mount Sinai journal of medicine, 65(4), 1998, pp. 289-291
69. HEINEMANN L; WOODWORTH J
    PHARMACOKINETICS AND GLUCODYNAMICS OF INSULIN LISPRO
    Medicamentos de actualidad
    
    L. Heinemann e J. Woodworth, "PHARMACOKINETICS AND GLUCODYNAMICS OF INSULIN LISPRO", Medicamentos de actualidad, 34, 1998, pp. 23-36
70. TOTH EL; LEE KC
    GUIDELINES FOR USING INSULIN LISPRO
    Canadian family physician
    
    E.L. Toth e K.C. Lee, "GUIDELINES FOR USING INSULIN LISPRO", Canadian family physician, 44, 1998, pp. 2444-2449
71. LUO C; CHEN J; LI HL; LI JS
    SPATIAL AND TEMPORAL EXPRESSION OF C-FOS PROTEIN IN THE SPINAL-CORD OF ANESTHETIZED RAT INDUCED BY SUBCUTANEOUS BEE VENOM INJECTION
    Brain research
    
    C. Luo et al., "SPATIAL AND TEMPORAL EXPRESSION OF C-FOS PROTEIN IN THE SPINAL-CORD OF ANESTHETIZED RAT INDUCED BY SUBCUTANEOUS BEE VENOM INJECTION", Brain research, 806(2), 1998, pp. 175-185
72. NOBLE SL; JOHNSTON E; WALTON B
    INSULIN LISPRO - A FAST-ACTING INSULIN ANALOG
    American family physician
    
    S.L. Noble et al., "INSULIN LISPRO - A FAST-ACTING INSULIN ANALOG", American family physician, 57(2), 1998, pp. 279-286
73. TORLONE E
    RECOMBINANT HUMAN INSULIN ANALOGS - RECOMMENDATIONS FOR OPTIMAL USE
    Biodrugs
    
    E. Torlone, "RECOMBINANT HUMAN INSULIN ANALOGS - RECOMMENDATIONS FOR OPTIMAL USE", Biodrugs, 9(5), 1998, pp. 363-374
74. Malin, DH; Lake, JR; Shenoi, M; Upchurch, TP; Johnson, SC; Schweinle, WE; Cadle, CD
    The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat
    PSYCHOPHARMACOLOGY
    
    D.H. Malin et al., "The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat", PSYCHOPHAR, 140(3), 1998, pp. 371-377
75. FLOATE KD; TAYLOR WG; SPOONER RW
    THIN-LAYER CHROMATOGRAPHIC DETECTION OF IVERMECTIN IN CATTLE DUNG
    Journal of chromatography B. Biomedical sciences and applications
    
    K.D. Floate et al., "THIN-LAYER CHROMATOGRAPHIC DETECTION OF IVERMECTIN IN CATTLE DUNG", Journal of chromatography B. Biomedical sciences and applications, 694(1), 1997, pp. 246-251
76. NAUCK MA; HOLST JJ; WILLMS B; SCHMIEGEL W
    GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AS A NEW THERAPEUTIC APPROACH FOR TYPE-2-DIABETES
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
    
    M.A. Nauck et al., "GLUCAGON-LIKE PEPTIDE-1 (GLP-1) AS A NEW THERAPEUTIC APPROACH FOR TYPE-2-DIABETES", EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(4), 1997, pp. 187-195
77. MCCRIMMON RJ; FRIER BM
    SYMPTOMATIC AND PHYSIOLOGICAL-RESPONSES TO HYPOGLYCEMIA-INDUCED BY HUMAN SOLUBLE INSULIN AND THE ANALOG LISPRO HUMAN INSULIN
    Diabetic medicine
    
    R.J. Mccrimmon e B.M. Frier, "SYMPTOMATIC AND PHYSIOLOGICAL-RESPONSES TO HYPOGLYCEMIA-INDUCED BY HUMAN SOLUBLE INSULIN AND THE ANALOG LISPRO HUMAN INSULIN", Diabetic medicine, 14(11), 1997, pp. 929-936
78. BRUNETTI P; BOLLI GB
    PHARMACOKINETICS AND PHARMACODYNAMICS OF INSULIN - RELEVANCE TO THE THERAPY OF DIABETES-MELLITUS
    Diabetes, nutrition & metabolism
    
    P. Brunetti e G.B. Bolli, "PHARMACOKINETICS AND PHARMACODYNAMICS OF INSULIN - RELEVANCE TO THE THERAPY OF DIABETES-MELLITUS", Diabetes, nutrition & metabolism, 10(1), 1997, pp. 24-34
79. LUTZ R; PEDAL I; WETZEL C; MATTERN R
    INSULIN INJECTION SITES - MORPHOLOGY AND IMMUNOHISTOCHEMISTRY
    Forensic science international
    
    R. Lutz et al., "INSULIN INJECTION SITES - MORPHOLOGY AND IMMUNOHISTOCHEMISTRY", Forensic science international, 90(1-2), 1997, pp. 93-101
80. THOMAS DP
    DOES LOW-MOLECULAR-WEIGHT HEPARIN CAUSE LESS BLEEDING
    Thrombosis and haemostasis
    
    D.P. Thomas, "DOES LOW-MOLECULAR-WEIGHT HEPARIN CAUSE LESS BLEEDING", Thrombosis and haemostasis, 78(6), 1997, pp. 1422-1425
81. HOFFMAN A; ZIV E
    PHARMACOKINETIC CONSIDERATIONS OF NEW INSULIN FORMULATIONS AND ROUTESOF ADMINISTRATION
    Clinical pharmacokinetics
    
    A. Hoffman e E. Ziv, "PHARMACOKINETIC CONSIDERATIONS OF NEW INSULIN FORMULATIONS AND ROUTESOF ADMINISTRATION", Clinical pharmacokinetics, 33(4), 1997, pp. 285-301
82. WILSON DM; BERGERT JH; LARSON TS; LIEDTKE RR
    GFR DETERMINED BY NONRADIOLABELLED IOTHALAMATE USING CAPILLARY ELECTROPHORESIS
    American journal of kidney diseases
    
    D.M. Wilson et al., "GFR DETERMINED BY NONRADIOLABELLED IOTHALAMATE USING CAPILLARY ELECTROPHORESIS", American journal of kidney diseases, 30(5), 1997, pp. 646-652
83. BLONDIN P; GUILBAULT LA; SIRARD MA
    THE TIME-INTERVAL BETWEEN FSH-P ADMINISTRATION AND SLAUGHTER CAN INFLUENCE THE DEVELOPMENTAL COMPETENCE OF BEEF HEIFER OOCYTES
    Theriogenology
    
    P. Blondin et al., "THE TIME-INTERVAL BETWEEN FSH-P ADMINISTRATION AND SLAUGHTER CAN INFLUENCE THE DEVELOPMENTAL COMPETENCE OF BEEF HEIFER OOCYTES", Theriogenology, 48(5), 1997, pp. 803-813
84. GOKE B; FEHMANN HC; SCHIRRA J; HARETER A; GOKE R
    GLUCAGON-LIKE PEPTIDE-1 [GLP-1] - A GUT H ORMONE ON ITS WAY FROM BENCH TO BESIDE
    Zeitschrift fur Gastroenterologie
    
    B. Goke et al., "GLUCAGON-LIKE PEPTIDE-1 [GLP-1] - A GUT H ORMONE ON ITS WAY FROM BENCH TO BESIDE", Zeitschrift fur Gastroenterologie, 35(4), 1997, pp. 285-294
85. SOLBERG Y; ALCALAY M; BELKIN M
    OCULAR INJURY BY MUSTARD GAS
    Survey of ophthalmology
    
    Y. Solberg et al., "OCULAR INJURY BY MUSTARD GAS", Survey of ophthalmology, 41(6), 1997, pp. 461-466
86. BOHANNON NJV
    BENEFITS OF LISPRO INSULIN - CONTROL OF POSTPRANDIAL GLUCOSE-LEVELS IS WITHIN REACH
    Postgraduate medicine
    
    N.J.V. Bohannon, "BENEFITS OF LISPRO INSULIN - CONTROL OF POSTPRANDIAL GLUCOSE-LEVELS IS WITHIN REACH", Postgraduate medicine, 101(2), 1997, pp. 73
87. HOLLEMAN F; HOEKSTRA JBL
    DRUG-THERAPY - INSULIN LISPRO
    The New England journal of medicine
    
    F. Holleman e J.B.L. Hoekstra, "DRUG-THERAPY - INSULIN LISPRO", The New England journal of medicine, 337(3), 1997, pp. 176-183
88. BURGE MR; WATERS DL; HOLCOMBE JH; SCHADE DS
    PROLONGED EFFICACY OF SHORT-ACTING INSULIN LISPRO COMBINATION WITH HUMAN ULTRALENTE IN INSULIN-DEPENDENT DIABETES-MELLITUS
    The Journal of clinical endocrinology and metabolism
    
    M.R. Burge et al., "PROLONGED EFFICACY OF SHORT-ACTING INSULIN LISPRO COMBINATION WITH HUMAN ULTRALENTE IN INSULIN-DEPENDENT DIABETES-MELLITUS", The Journal of clinical endocrinology and metabolism, 82(3), 1997, pp. 920-924
89. GALLWITZ B; SCHMIDT WE
    INSULIN ANALOGS AND NEW ANTIDIABETICS - O UTLOOK FOR TREATING DIABETES
    Der Internist
    
    B. Gallwitz e W.E. Schmidt, "INSULIN ANALOGS AND NEW ANTIDIABETICS - O UTLOOK FOR TREATING DIABETES", Der Internist, 38(6), 1997, pp. 617-624
90. WILDE MI; MCTAVISH D
    INSULIN LISPRO - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF DIABETES-MELLITUS
    Drugs
    
    M.I. Wilde e D. Mctavish, "INSULIN LISPRO - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE IN THE MANAGEMENT OF DIABETES-MELLITUS", Drugs, 54(4), 1997, pp. 597-614
91. RACHMAN J; BARROW BA; LEVY JC; TURNER RC
    NEAR-NORMALIZATION OF DIURNAL GLUCOSE-CONCENTRATIONS BY CONTINUOUS ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) IN SUBJECTS WITH NIDDM
    Diabetologia
    
    J. Rachman et al., "NEAR-NORMALIZATION OF DIURNAL GLUCOSE-CONCENTRATIONS BY CONTINUOUS ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1 (GLP-1) IN SUBJECTS WITH NIDDM", Diabetologia, 40(2), 1997, pp. 205-211
92. CAMPBELL RK; CAMPBELL LK; WHITE JR
    INSULIN LISPRO - ITS ROLE IN THE TREATMENT OF DIABETES-MELLITUS
    The Annals of pharmacotherapy
    
    R.K. Campbell et al., "INSULIN LISPRO - ITS ROLE IN THE TREATMENT OF DIABETES-MELLITUS", The Annals of pharmacotherapy, 30(11), 1996, pp. 1263-1271
93. BARRI YM; RAMOS EL; BALAGTAS RS; PETERSON JC; KARLIX JL
    CIMETIDINE OR RANITIDINE IN RENAL-TRANSPLANT PATIENTS RECEIVING CYCLOSPORINE
    Clinical transplantation
    
    Y.M. Barri et al., "CIMETIDINE OR RANITIDINE IN RENAL-TRANSPLANT PATIENTS RECEIVING CYCLOSPORINE", Clinical transplantation, 10(1), 1996, pp. 34-38
94. MIDDLETON RK; LYLE JA; BERGER DL
    KETOROLAC CONTINUOUS-INFUSION - A CASE-REPORT AND REVIEW OF THE LITERATURE
    Journal of pain and symptom management
    
    R.K. Middleton et al., "KETOROLAC CONTINUOUS-INFUSION - A CASE-REPORT AND REVIEW OF THE LITERATURE", Journal of pain and symptom management, 12(3), 1996, pp. 190-194
95. BYRNE MM; GOKE B
    HUMAN STUDIES WITH GLUCAGON-LIKE-PEPTIDE-1 - POTENTIAL OF THE GUT HORMONE FOR CLINICAL USE
    Diabetic medicine
    
    M.M. Byrne e B. Goke, "HUMAN STUDIES WITH GLUCAGON-LIKE-PEPTIDE-1 - POTENTIAL OF THE GUT HORMONE FOR CLINICAL USE", Diabetic medicine, 13(10), 1996, pp. 854-860
96. MARTIN S; JONES JS; WYNN BN
    DOES WARMING LOCAL-ANESTHETIC REDUCE THE PAIN OF SUBCUTANEOUS INJECTION
    The American journal of emergency medicine
    
    S. Martin et al., "DOES WARMING LOCAL-ANESTHETIC REDUCE THE PAIN OF SUBCUTANEOUS INJECTION", The American journal of emergency medicine, 14(1), 1996, pp. 10-12
97. BRADBERRY SM; FELDMAN MA; BRAITHWAITE RA; SHORTLANDWEBB W; VALE JA
    ELEMENTAL MERCURY-INDUCED SKIN GRANULOMA - A CASE-REPORT AND REVIEW OF THE LITERATURE
    Journal of toxicology. Clinical toxicology
    
    S.M. Bradberry et al., "ELEMENTAL MERCURY-INDUCED SKIN GRANULOMA - A CASE-REPORT AND REVIEW OF THE LITERATURE", Journal of toxicology. Clinical toxicology, 34(2), 1996, pp. 209-216
98. PINELLI L; GONFIANTINI E
    NEW INSULINS
    Rivista italiana di pediatria
    
    L. Pinelli e E. Gonfiantini, "NEW INSULINS", Rivista italiana di pediatria, 22(4), 1996, pp. 605-611
99. KUNO T; TASAKI H; MIYAZAKI S
    CONTINUOUS SUBCUTANEOUS INSULIN INJECTION FOR SELF-CARE OF YOUNG-PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS
    Acta Paediatrica Japonica Overseas Edition
    
    T. Kuno et al., "CONTINUOUS SUBCUTANEOUS INSULIN INJECTION FOR SELF-CARE OF YOUNG-PATIENTS WITH INSULIN-DEPENDENT DIABETES-MELLITUS", Acta Paediatrica Japonica Overseas Edition, 38(5), 1996, pp. 464-469
100. RAPAPORT MJ; VINNIK C; ZAREM H
     INJECTABLE SILICONE - CAUSE OF FACIAL NODULES, CELLULITIS, ULCERATION, AND MIGRATION
     Aesthetic plastic surgery
     
     M.J. Rapaport et al., "INJECTABLE SILICONE - CAUSE OF FACIAL NODULES, CELLULITIS, ULCERATION, AND MIGRATION", Aesthetic plastic surgery, 20(3), 1996, pp. 267-276